This protocol delineates a comprehensive method for synthesizing and preparing Metal-Organic Framework (MOF) nanoparticles, incorporating a STING agonist (2'3'-cGAMP). The process begins with the dissolution of Zirconium(IV) Chloride Octahydrate and Benzoic Acid in Dimethylformamide (DMF), followed by the addition of Meso-Tetraphenylporphine. The mixture undergoes ultrasonic dispersion and heating to form MOFs. Subsequent centrifugation and washing steps purify the MOFs, which are then combined with the STING agonist. The protocol also details cell harvesting and lysis procedures for preparing cellular components. The final steps include the filtration and volume adjustment of the MOF, MOF+STING, and cell membrane preparations, ensuring their readiness for biological applications. This methodical approach is essential for generating functional MOF nanoparticles for use in various in vivo and in vitro studies, particularly in molecular and cellular research.